Child Health Program
- Wave 3 follow-up of Aboriginal birth cohort adolescents. Click here to read more. Click here to view ABC clan cohort website.
- Diabetes risk markers in Wave 3 of the Aboriginal Birth Cohort Study. Click here to read more.
- Cardiovascular risk factors in Aboriginal Birth cohort adolescents. Click here to read more.
- Risk of heart disease for Aboriginal adolescents. Click here to read more.
- Investigation of oral health among Aboriginal people involved in a longitudinal study. Click here to read more.
- Hepatitis B immunity in Indigenous and “at risk” children who received hepatitis B vaccination in infancy. Click here to read more.
- Invasive Acinetobacter infection in the tropical NT. Click here to read more.
- The EarInfonet Project – A National Indigenous Ear Health and Hearing Web Resource and Network. Click here to read more.<
- Implications of bacterial load for vaccine efficacy and antibiotic treatment outcomes in high-risk populations (BLOOM = Bacterial load on outcomes of otitis media). Click here to open.
- Pneumococcal surveillance in the Northern Territory: Implications of vaccination and mass treatment programs (MARS – Monitoring antibiotic resistance and serotypes).Click here to read more.
- Development and evaluation of a primary health care model to prevent dental decay in Aboriginal pre-school children “Strong Teeth for Little Kids” (STLK. Click here to read more.
- A prospective study of Aboriginal children with bronchiectasis or chronic moist cough with or without CXR infiltrates : an international multicentre study (Bronchiectasis Observational Study – BOS). Click here to read more.
- Immunogenecity of 7-valent pneumococcal conjugate vaccine (Prevenar) in Tiwi infants (PARTI = Pneumococcal Antibody Responses in Tiwi infants)> Click here to read more.
- Ciprofloxacin versus Sofradex use in runny ears (C-SURE). Click here to read more.
- Implications of nonencapsulated Streptococcus pneumoniae carriage for maintenance of antibiotic resistance genes the efficacy of pneumococcal conjugate vaccine (Prevenar) for pneumococcal disease. (Streptococcus Pneumoniae: Implications of Nonencapsulated Isolates for Carriage And Resistance; SPINICAR. Click here to read more.
- PneuMum: Immunising Aboriginal mothers with pneumococcal polysaccharide vaccine to prevent infant ear disease and pneumococcal carriage. Click here to read more.
- Vaccine interactions between 7-valent pneumococcal conjugate vaccine, Prevenar, and the scheduled diphtheria, tetanus and pertussis (DTP) and Haemophilus influenzae type b (Hib) vaccines, in Tiwi infants (VISIT = Vaccine Interaction Study in the Tiwi)Click here to read more.
- Azithromycin versus Amoxycillin for the treatment of acute otitis media in Aboriginal children (AATAAC). Click here to read more.
- Reducing the burden of infectious disease in young Aboriginal children: An evidence-based multidisciplinary approach. Click here to open.
- Community Pneumococcal Protection Project (CPPP). Click here to read more.
- Otitis media in Indigenous and non-Indigenous children : Microbiological and immunological risk factors (WAHI). Click here to read more.
- 5th International Symposium on Pneumococci and Pneumococcal Diseases. Click here to read more.
- Selective use of long-term antibiotics for chronic lung obstructive disease in Aboriginal adults: a multi-centre trial. Click here to read more.<
|
|
Child Health